Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Pivotal S.L.
Information provided by (Responsible Party):
Grupo Oncológico Gallego
ClinicalTrials.gov Identifier:
NCT00721747
First received: July 23, 2008
Last updated: March 15, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2015
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)